Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine were announced today by investigators at Dartmouth's Geisel School of Medicine and published in the journal Vaccine. The three-year trial was conducted ...
Sep 29, 2020
0
3
Although COVID-19 commands the headlines today, tuberculosis (TB) remains the biggest infection killer in the world and multiple drug resistant TB, which does not respond to regular antibiotics, continues to be a major threat ...
May 13, 2020
0
58
Young children exposed to tuberculosis are at surprisingly high risk of developing the disease, according to research led by the School of Medicine.
Mar 20, 2020
0
55
Tuberculosis (TB) is one of the world's most vexing public health problems. About 1.5 million people died from this bacterial lung infection in 2018, and the World Health Organization (WHO) estimates that one-quarter of the ...
Jan 30, 2020
0
77
Lengthy negotiations ended in good news recently when the price of rifapentine, a lifesaving antibiotic, was marked down by 66% by its manufacturer Sanofi. When combined with another antibiotic (isoniazid), rifapentine can ...
Jan 14, 2020
0
3
What if you could make the tuberculosis vaccine much more powerful, not by altering the ingredients, but just by changing the way it is given to people? It would help prevent the infection that kills more people every year ...
Jan 3, 2020
0
4
A major goal of tuberculosis (TB) research is to find a way to treat people with the latent (or inactive) form of the disease to keep them from developing symptomatic TB. A breakthrough study using a new animal model developed ...
Dec 17, 2019
0
54
Important gains have been made in the global fight against tuberculosis (TB). Each year, fewer people are being diagnosed with the disease. The recent World Health Organisation (WHO) global TB report, which gathers data from ...
Nov 11, 2019
0
1
A new analysis challenges the longstanding notion that tuberculous infection is a life-long infection that could strike at any time and cause tuberculosis (TB). Based on a review of clinical studies, researchers from the ...
Oct 25, 2019
0
94
(HealthDay)—An estimated 12.6 million persons in the United States could benefit from treatment to prevent active tuberculosis (TB), according to a report published in the October issue of Emerging Infectious Diseases, ...
Sep 19, 2019
0
0
